No Data
Hainan Development: Report for the first quarter of 2025
Hainan Development: Briefing on the main business conditions of the decoration business in the first quarter of 2025
Sanbo Neuroscience (301293.SZ): No plans to develop in Hainan Development Holdings Nanhai at this time.
Gelonghui April 23丨Sanbo Neuroscience (301293.SZ) stated on the interactive platform that the company currently operates 8 Hospitals, located in Peking, Chongqing, Kunming, Fujian, Chengdu, and Zhengzhou and Luoyang in Henan, with two more Hospitals under construction in Xi'an and Hunan; there are currently no plans for Hainan Development Holdings Nanhai.
Hainan Development: 2024 Annual Report
Hainan Development: 2024 Annual Report Summary
Minority Shareholders can't wait three years? Hainan Development Holdings Nanhai's duty-free Assets injection faces another reversal as the controlling Shareholder's delay is unsuccessful | Quick read announcement.
① The proposal for Hainan Development Holdings Nanhai to postpone the fulfillment of the commitment regarding the injection of Duty Free Shop Concept assets was not approved by the shareholders' meeting; ② In 2020, the company's controlling shareholder changed to Hainan Holdings, and the Duty Free Shop Concept became a significant trend in the market, with Hainan Development once becoming a big bull stock; ③ After a second reversal, there is currently less than a month until the originally scheduled commitment expiration date, making the subsequent developments of this event worth watching.
Revenues Not Telling The Story For Hainan Development HoldingsNanhai Co., Ltd. (SZSE:002163)